Baxter (BAX) Financial Analysis & Valuation | Quarter Chart
Baxter (BAX)
BAXPrice: $22.02
Fair Value: 🔒
🔒score
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug recon... more
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare... more
Description
Shares
| Market Cap | $11.37B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Andrew Hider |
| IPO Date | 1981-10-27 | CAGR | 0.04% |
| Employees | 38,000 | Website | www.baxter.com |
| Div. Yield | 1.44% | Payout Ratio | -0.24% |
| Buy Back Yield | — | Total Yield | 1.44% |
BAX chart loading...
Fundamentals
Technicals
| Enterprise Value | $17.67B | P/E Ratio | 10.59 |
| Forward P/E | 10.94 | PEG Ratio | — |
| P/S Ratio | 1.15 | P/B Ratio | 2.12 |
| P/CF Ratio | 10.28 | P/FCF Ratio | 18.06 |
| EPS | $2.08 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 5.1% | Gross Margin | 0.3% |
| Operating Margin | -0.03% | Profit Margin | -0.1% |
| ROE | -0.16% | ROA | -0.06% |
| ROCE | -0.02% | Current Ratio | 1.85 |
| Quick Ratio | 1.23 | Cash Ratio | 0.55 |
| Debt/Equity | 1.6 | Interest Coverage | -1.09 |
| Altman Z Score | 2.18 | Piotroski Score | 5 |